AstraZeneca ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.

Donald Trump’s push to restrict US investments in China is testing what in theory should be an ironclad financial ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The private election watchdog has mentioned a series of issues, including potential horse-trading, shrinking public ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Repsol, S.A. has outperformed the S&P 500 by nearly 20%, including dividends and FX, making it a strong pick. Find out why I ...

Under strategic action plan 2024-26 to develop Islamic finance in the non-bank financial sector, the SECP intends to introduce an alternate dispute resolution (ADR) mechanism for Islamic finance ...

No fractional new ADSs will be issued in connection with the Ratio Change. Rather, fractional entitlements to new ADSs will be aggregated and sold by the depositary bank, and the net cash proceeds ...

Amarin (AMRN) announced its intent to effect a ratio change on its American Depositary Shares from one ADS representing one ordinary share, to ...

Lifco’s strong fundamentals are overshadowed by high multiples. Find out why LFABF stock is overvalued and rated "Hold" with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...